This protocol addresses abducens nerve palsy in patients under 18 years of age where there is an identified risk of amblyopia. Young children with abducens nerve palsy are particularly vulnerable to amblyopia due to the visual suppression that can occur when binocular alignment is disrupted during a critical window of visual development.
Young children with abducens nerve palsy are vulnerable to amblyopia. The suppression of input from the affected eye during early childhood can lead to a lasting reduction in visual acuity if not actively managed. Intervention must address both the palsy itself and the risk to equal visual development between the eyes.
The primary management strategy in this population centres on occlusion-based intervention directed at amblyopia prevention. The specific approach — including which method is selected and how it is applied — depends on the individual clinical picture.
The clinical objective is equal visual development between the eyes, with confirmed absence of amblyopia as the primary endpoint.
DOI: 10.1016/j.apjo.2026.100297
Young children with abducens nerve palsy are vulnerable to amblyopia. Occlusion therapy remains the primary strategy for amblyopia management.
It can also be employed to promote equal visual development and prevent amblyopia in children.
View source ↗